RE:RE:RE:RE:RE:RE:RE:RE:Absurd to call these publicly-traded companiesQuit blaming the company for the sweetheart financing deal. If you want to lay blame, then start with Mackie and the crooked Bay and Wall Street brokers.
TLT was virtually powerless to stop what happened.
tomchoco wrote: No one disputes the strides they have made on the medical side. It is the way the offering was handled that is the issue. They set up shareholders who were buying in 50% higher on a string of PR's knowing full well the prospectus offering was going off at a very low number. That is the issue. No matter where the stock ends up, I would not trust these people to do us right on a partnership or future offerings. It was a scumbag move.
They need a solid business mind who will have the ear of institutions and pharma when the time comes for a deal. That is what I am asking for. JMHO